{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:53:36Z","timestamp":1776128016219,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pediatric acute lymphoblastic leukemia (ALL) is the most common neoplasm and one of the primary causes of death in children. Its treatment is highly dependent on the correct classification of subtype. Previously, we developed a microarray-based subtype classifier based on the relative expression levels of 62 marker genes, which can predict 7 different ALL subtypes with an accuracy as high as 97% in completely independent samples. Because the classifier is based on gene expression rank values rather than actual values, the classifier enables an individualized diagnosis, without the need to reference the background distribution of the marker genes in a large number of other samples and also enables cross platform application. Here, we demonstrate that the classifier can be extended from a microarray-based technology to a multiplex qPCR-based technology using the same set of marker genes as the advanced fragment analysis (AFA). Compared to microarray assays, the new assay system makes the convenient, low cost and individualized subtype diagnosis of pediatric ALL a reality and is clinically applicable, particularly in developing countries.<\/jats:p>","DOI":"10.1038\/srep12435","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T14:12:58Z","timestamp":1437487978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["An advanced fragment analysis-based individualized subtype classification of pediatric acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"5","author":[{"given":"Han","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilai","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Dong J.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huyong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,21]]},"reference":[{"key":"BFsrep12435_CR1","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","volume":"104","author":"CH Pui","year":"2004","unstructured":"Pui, C. H. et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children\u2019s Research Hospital. Blood 104, 2690\u20132696 (2004).","journal-title":"Blood"},{"key":"BFsrep12435_CR2","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1200\/JCO.2005.00.554","volume":"23","author":"G Gatta","year":"2005","unstructured":"Gatta, G. et al. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 23, 3742\u20133751 (2005).","journal-title":"J Clin Oncol"},{"key":"BFsrep12435_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel, R., Ward, E., Brawley, O. & Jemal, A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61, 212\u2013236 (2011).","journal-title":"CA Cancer J Clin"},{"key":"BFsrep12435_CR4","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","volume":"120","author":"CH Pui","year":"2012","unstructured":"Pui, C. H., Mullighan, C. G., Evans, W. E. & Relling, M. V. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood 120, 1165\u20131174 (2012).","journal-title":"Blood"},{"key":"BFsrep12435_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui, C. H. & Evans, W. E. Treatment of acute lymphoblastic leukemia. N Engl J Med 354, 166\u2013178 (2006).","journal-title":"N Engl J Med"},{"key":"BFsrep12435_CR6","doi-asserted-by":"crossref","unstructured":"Carroll, W. L. et al. Pediatric acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program, 102\u2013131, 10.1182\/asheducation-2003.1.102 (2003).","DOI":"10.1182\/asheducation-2003.1.102"},{"key":"BFsrep12435_CR7","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","volume":"28","author":"T Haferlach","year":"2010","unstructured":"Haferlach, T. et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol 28, 2529\u20132537 (2010).","journal-title":"J Clin Oncol"},{"key":"BFsrep12435_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1471-2407-6-229","volume":"6","author":"K Hoffmann","year":"2006","unstructured":"Hoffmann, K., Firth, M. J., Beesley, A. H., de Klerk, N. H. & Kees, U. R. Translating microarray data for diagnostic testing in childhood leukaemia. BMC Cancer 6, 229 (2006).","journal-title":"BMC Cancer"},{"key":"BFsrep12435_CR9","first-page":"890","volume":"90","author":"C De Pitta","year":"2005","unstructured":"De Pitta, C. et al. A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia. Haematologica 90, 890\u2013898 (2005).","journal-title":"Haematologica"},{"key":"BFsrep12435_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","volume":"10","author":"ML Den Boer","year":"2009","unstructured":"Den Boer, M. L. et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol 10, 125\u2013134 (2009).","journal-title":"Lancet Oncol"},{"key":"BFsrep12435_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/gcc.20616","volume":"48","author":"S Bungaro","year":"2009","unstructured":"Bungaro, S. et al. Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks. Genes Chromosomes Cancer 48, 22\u201338 (2009).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFsrep12435_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1755-8794-2-64","volume":"2","author":"X Wang","year":"2009","unstructured":"Wang, X. & Gotoh, O. Accurate molecular classification of cancer using simple rules. BMC Med Genomics 2, 64 (2009).","journal-title":"BMC Med Genomics"},{"key":"BFsrep12435_CR13","doi-asserted-by":"publisher","first-page":"11141","DOI":"10.1093\/nar\/16.23.11141","volume":"16","author":"JS Chamberlain","year":"1988","unstructured":"Chamberlain, J. S., Gibbs, R. A., Ranier, J. E., Nguyen, P. N. & Caskey, C. T. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 16, 11141\u201311156 (1988).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep12435_CR14","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1182\/blood-2009-08-239681","volume":"116","author":"RC Harvey","year":"2010","unstructured":"Harvey, R. C. et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics and outcome. Blood 116, 4874\u20134884 (2010).","journal-title":"Blood"},{"key":"BFsrep12435_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/leu.2013.206","volume":"28","author":"L Olsson","year":"2014","unstructured":"Olsson, L. et al. Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011. Leukemia 28, 302\u2013310 (2014).","journal-title":"Leukemia"},{"key":"BFsrep12435_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3324\/haematol.2011.056135","volume":"98","author":"P Dorge","year":"2013","unstructured":"Dorge, P. et al. IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. Haematologica 98, 428\u2013432 (2013).","journal-title":"Haematologica"},{"key":"BFsrep12435_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJMoa0808253","volume":"360","author":"CG Mullighan","year":"2009","unstructured":"Mullighan, C. G. et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360, 470\u2013480 (2009).","journal-title":"N Engl J Med"},{"key":"BFsrep12435_CR18","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1182\/blood-2009-04-218123","volume":"114","author":"Z Li","year":"2009","unstructured":"Li, Z. et al. Gene expression-based classification and regulatory networks of pediatric acute lymphoblastic leukemia. Blood 114, 4486\u20134493 (2009).","journal-title":"Blood"},{"key":"BFsrep12435_CR19","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1182\/blood-2010-12-324004","volume":"117","author":"E Coustan-Smith","year":"2011","unstructured":"Coustan-Smith, E. et al. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood 117, 6267\u20136276 (2011).","journal-title":"Blood"},{"key":"BFsrep12435_CR20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/leu.2008.386","volume":"23","author":"M Zaliova","year":"2009","unstructured":"Zaliova, M. et al. Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR\/ABL-positive ALL: implications for residual disease monitoring. Leukemia 23, 944\u2013951 (2009).","journal-title":"Leukemia"},{"key":"BFsrep12435_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2353\/jmoldx.2007.060111","volume":"9","author":"QR Chen","year":"2007","unstructured":"Chen, Q. R. et al. Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction. J Mol Diagn 9, 80\u201388 (2007).","journal-title":"J Mol Diagn"},{"key":"BFsrep12435_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jmoldx.2010.10.001","volume":"13","author":"JE Drew","year":"2011","unstructured":"Drew, J. E., Mayer, C. D., Farquharson, A. J., Young, P. & Barrera, L. N. Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp and tumor tissue. J Mol Diagn 13, 233\u2013242 (2011).","journal-title":"J Mol Diagn"},{"key":"BFsrep12435_CR23","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00216-008-2436-7","volume":"393","author":"AJ Rai","year":"2009","unstructured":"Rai, A. J., Kamath, R. M., Gerald, W. & Fleisher, M. Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling. Anal Bioanal Chem 393, 1505\u20131511 (2009).","journal-title":"Anal Bioanal Chem"},{"key":"BFsrep12435_CR24","doi-asserted-by":"crossref","unstructured":"Zhang, P. J. et al. Peripheral blood mRNA expression patterns to differentiate hepatocellular carcinoma from other hepatic diseases. Front Biosci ( Elite Ed) 4, 620\u2013630 (2012).","DOI":"10.2741\/e404"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep12435","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep12435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep12435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T14:39:19Z","timestamp":1672929559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep12435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,21]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,18]]}},"alternative-id":["BFsrep12435"],"URL":"https:\/\/doi.org\/10.1038\/srep12435","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,21]]},"assertion":[{"value":"19 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The 57 marker genes and the SVM classifier described here have been submitted for patent (application No. 201410250033.1) by part of the authors including H. Zheng, J.D.J.H., Y.W., S.B., H. Zhang, H.C., R.Z., L.N., Q.W., X.Z. and Y.C.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12435"}}